Michael Kauffman, Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), sold 15,000 shares at $18.50 ($275K) on 2020-06-09, disclosed to the SEC on 2020-06-11.
Open-market sale of $275k KPTI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.50 | 7,500 | $139K | 50.5% |
| 2 | $18.13 | 7,500 | $136K | 49.5% |
| Total | $18.32 avg | 15,000 | $275K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |